Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Recognizing warning signs of a bad cryptocurrency investment can save you from significant losses. Stay alert and informed with our guide.
18,904 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Investors are watching Micron ahead of earnings day. This guide breaks down three essential signals that could push M...
Micah Lasher won a crowded Democratic primary in Manhattan, delivering a setback to the Kennedy legacy. The race also...
A notable insider transaction at REX raised questions for investors. This guide explains what investors should know, ...
The AI boom has investors asking: marvell technology: which will become the next trillion-dollar stock. This article ...
Micron Technology posted blowout Q3 2026 results, sending shares higher and lifting SanDisk and Western Digital as in...
Poet Technologies faces a pivotal year as AI-driven optical interconnects scale. This report analyzes catalysts, risk...
When one tech giant climbs and another stumbles, the market often stays coldsweat steady. Learn how Micron’s strength...
As SpaceX IPO chatter grows, investors seek breadth over a single-name bet. A diversified space ETF offers exposure t...
GPIQ has drawn billions with a near-10% yield by selling call options on mega-cap tech. The strategy injects income b...
What happens when AI breakthroughs and high-flying tech bets collide with political markets? This article explains th...
When Alphabet joins the Dow Jones Industrial Average, it signals a shift in how blue-chip names are chosen and weight...